Dr. Daphne Scaramangas-Plumley, MD

Dr. Scaramangas-Plumley practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Scaramangas-Plumley's NPI, 1073878229, was assigned on July 12, 2012. Dr. Scaramangas-Plumley graduated from Ross University School of Medicine in 2012. Dr. Scaramangas-Plumley holds California license A135975.

Dr. Scaramangas-Plumley's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Scaramangas-Plumley's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Attune Health. Dmand AI also links Dr. Scaramangas-Plumley to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scaramangas-Plumley practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Scaramangas-Plumley's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Scaramangas-Plumley is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Scaramangas-Plumley's licenses on file in 4 states: California, Florida, Rhode Island and Massachusetts.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint cyst, joint pain and lupus among the conditions Dr. Scaramangas-Plumley treats.

CMS data shows 43,680 Medicare services from Dr. Scaramangas-Plumley across 39 procedure codes in 2024, for 512 Medicare patients. Medicare paid $813,476 for them. Every service was in an office.

CMS counts 512 Medicare patients who saw Dr. Scaramangas-Plumley in 2024. The largest group is 65 to 74, with 241 patients. 75% of them have high cholesterol, and 73% have arthritis. 9% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Scaramangas-Plumley's median patient age at 72, with 80% women.

In 2024, Dr. Scaramangas-Plumley wrote 966 Medicare Part D claims for 180 patients. 83% of them were for generic drugs. CMS names the drug for 727 of them, across 23 drugs with 11 or more claims each, at $596,631 in total drug cost. In 2023, CMS named 753 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Scaramangas-Plumley for performance year 2024, reported as part of a group. Dr. Scaramangas-Plumley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Scaramangas-Plumley as offering telehealth.

Dmand AI links 1 paper to Dr. Scaramangas-Plumley in 2025. Dr. Scaramangas-Plumley's most frequent co-authors are Rohit Aggarwal, MD, Joe T. Kelley, MD and Shalini Mahajan, MD.

CMS Open Payments shows 356 general payments to Dr. Scaramangas-Plumley from 25 drug and device companies from 2017 to 2025. Grants make up the largest share, 46% of the total. Pfizer Inc. paid the most, $65,074.

Dr. Scaramangas-Plumley graduated from Ross University School of Medicine in 2012.

Dr. Scaramangas-Plumley is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.